Bob Brams’s Top Medical Team
-
Henry Brem, MD
Henry Brem is the Harvey Cushing Professor of Neurosurgery at The Johns Hopkins University, Director of the Department of Neurosurgery, and Neurosurgeon-in-Chief. He also is a professor of Oncology, Ophthalmology, and Biomedical Engineering. Brem received his undergraduate degree from New York University, his medical degree from Harvard, and trained in neurosurgery at Columbia. At Hopkins, he has built one of the largest brain tumor research and treatment centers in the world.
-
Mitchel Berger, MD
Dr. Mitchel Berger is the Chief of Neurosurgery, University of California San Francisco Medicine (UCSF). Dr. Berger is a nationally recognized expert in treating brain and spinal cord tumors as well as tumor-related epilepsy in adults and children. He also is a specialist in brain mapping techniques – used to identify and preserve areas of motor, sensory and language function during surgery – and an expert in using the Gamma Knife, a precise, noninvasive tool that applies radiation beams for tumor treatment. He is director of the Brain Tumor Center, director of the Center for Neurological Injury and Repair and co-director of the Adult Brain Tumor Surgery Program. Dr. Berger serves as a Blue Ribbon Panelist on President Joe Biden’s Moonshot Program.
-
Mark Gilbert, MD
Dr. Mark Gilbert is Chief of the Neuro Oncology Branch at the National Institutes of Health. He has focused much of his effort to develop a unified team within the neuro-oncology branch at NIH in order to perform cutting- edge research that advances knowledge in the brain tumor a field.
-
John Laterra, MD
As Professor of Neurology, Oncology and Neuroscience and Co-Director of the Brain Cancer Disease Group at the Johns Hopkins Kimmel Cancer Center, Dr. John Laterra focuses on the diagnosis and treatment of patients with primary brain tumors and neurological complications of systemic cancer. Dr. Laterra is internationally recognized for his clinical expertise and research on mechanisms of brain tumor malignancy, tumor vascular biology and the identification of new therapeutic targets in gliomas.
-
Susan Chang, MD
Director, UCSF Neurosurgery Network Director of Quality Director, UCSF Neuro-Oncology Gordon Murray Caregiver Program. Dr. Chang is an internationally recognized leader in the field of neurological malignancies. She specializes in the treatment of adults with brain tumors, including glioblastomas and meningiomas. Dr. Chang’s research expertise is in clinical trial design and the development of novel therapies and imaging biomarkers for brain tumors.
-
Byram Ozer, MD
Dr. Ozer is a neuro-oncologist at the National Institutes of Health who cares for patients with rare brain and spine tumors as part of the NCI-CONNECT (Comprehensive Oncology Network Evaluating Rare CNS Tumors) program at the Neuro-Oncology Branch (NOB).
-
Javier Villanueva-Meyer, MD
Javier Villanueva-Meyer, MD, is an Assistant Professor of Clinical Radiology in the Neuroradiology subspecialty section in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. He received his medical degree from Baylor College of Medicine in Houston, Texas, and he completed his one-year internship at Virginia Tech Carilion School of Medicine in Roanoke. Dr. Villanueva-Meyer completed his four-year diagnostic radiology residency at the UCSF, followed by a Neuroradiology fellowship at UCSF. He also completed a NIH T32 post-doctoral fellowship in the UCSF Department of Radiology and Biomedical Imaging.